Tildrakizumab-asmn: What’s in a Name?
Crossref DOI link: https://doi.org/10.1007/s40257-018-0357-6
Published Online: 2018-04-23
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Eric J. http://orcid.org/0000-0002-3763-3309
Beck, Kristen M.
Liao, Wilson
Text and Data Mining valid from 2018-04-23
Article History
First Online: 23 April 2018
Compliance with Ethical Standards
:
: No funding was received for the preparation of this commentary.
: Eric J. Yang, Kristen M. Beck, and Wilson Liao have no conflicts of interest.